Moreover, research on pediatric MS patients indicated that 37.9% carried at least one heterozygous mutation in the TNFRSF1A gene, associated with TNF receptor-associated periodic fever syndrome, TRAPS, and/or MEFV gene. Here, MEFV is linked to myeloid sarcoma.